找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Nanotechnology; Ângela Maria Almeida de Sousa,Christiane Pienna So Book 2023 The Editor(s) (if applicable) and The Author(s), under

[复制链接]
查看: 44081|回复: 51
发表于 2025-3-21 18:38:13 | 显示全部楼层 |阅读模式
书目名称Cancer Nanotechnology
编辑Ângela Maria Almeida de Sousa,Christiane Pienna So
视频video
概述Presents a comprehensive overview of different areas of cancer nanotechnology.Addresses a broad spectrum of cutting-edge topics about materials in cancer nanotechnology.Provides students and trainees
图书封面Titlebook: Cancer Nanotechnology;  Ângela Maria Almeida de Sousa,Christiane Pienna So Book 2023 The Editor(s) (if applicable) and The Author(s), under
描述.Cancer nanotechnology is a growing, emerging area of cross-disciplinary research that aims to develop efficient, specific and noninvasive approaches to restore the health and well-being of all cancer patients through more effective diagnosis and treatment. This new volume serves as a fundamental guide to cutting-edge topics in cancer nanotechnology, including advances in therapy, the use of nanoparticles and nanomaterials, future directions for nanocarriers in cancer therapy, and the application of DNA and RNA nanovaccines..Organized into four sections, the volume presents an overview of research and innovation in the emerging field of nanotechnology as a powerful tool in the diagnosis, imaging and treatment of cancer. International experts author chapters addressing targets of cancer therapy, materials for cancer nanotechnology, strategies for cancer therapy using nanotechnology, and innovative nanotechnologies for cancer diagnosis and treatment. The volume will be useful fora broad audience, including cross-disciplinary researchers, trainees, health professionals, and experts in industry. .
出版日期Book 2023
关键词Nanobiopharmaceuticals; cancer therapies; epigenetics; cancer development; cancer prognosis; metastatic c
版次1
doihttps://doi.org/10.1007/978-3-031-17831-3
isbn_ebook978-3-031-17831-3
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Cancer Nanotechnology影响因子(影响力)




书目名称Cancer Nanotechnology影响因子(影响力)学科排名




书目名称Cancer Nanotechnology网络公开度




书目名称Cancer Nanotechnology网络公开度学科排名




书目名称Cancer Nanotechnology被引频次




书目名称Cancer Nanotechnology被引频次学科排名




书目名称Cancer Nanotechnology年度引用




书目名称Cancer Nanotechnology年度引用学科排名




书目名称Cancer Nanotechnology读者反馈




书目名称Cancer Nanotechnology读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:10:50 | 显示全部楼层
发表于 2025-3-22 03:31:31 | 显示全部楼层
Ângela Maria Almeida de Sousa,Christiane Pienna SoPresents a comprehensive overview of different areas of cancer nanotechnology.Addresses a broad spectrum of cutting-edge topics about materials in cancer nanotechnology.Provides students and trainees
发表于 2025-3-22 05:21:47 | 显示全部楼层
http://image.papertrans.cn/c/image/221158.jpg
发表于 2025-3-22 12:40:30 | 显示全部楼层
发表于 2025-3-22 13:24:50 | 显示全部楼层
G. Sarosy,L. Rubinstein,B. Leyland-Jones low selectivity toward tumor cells, since they also act on healthy tissues. Theranostics is a new field of nanomedicine, combining therapy, diagnosis, and real-time monitoring using imaging techniques. It is useful to monitor the biodistribution of the chemotherapeutic agent that can be activated i
发表于 2025-3-22 18:50:01 | 显示全部楼层
发表于 2025-3-23 00:17:51 | 显示全部楼层
https://doi.org/10.1007/978-3-642-83405-9 been strictly connected to the need of fabricating organ substitutes with minimal biological functionality for organ transplant’s purpose. In the latest years, thanks to the technological advances in biomaterial fields, bioprinting promoted the development of tissue constructs with biological funct
发表于 2025-3-23 02:24:55 | 显示全部楼层
UICC International Union Against Cancerting in fewer side effects. With the rise of genetic engineering, recombinant human or humanized mAbs are available in the market for the treatment of cancer, either in monotherapy, in association or conjugated with other drugs. Thus, monovalent or bispecific mAbs find applicability for their antitu
发表于 2025-3-23 07:18:07 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-2 07:14
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表